{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:41:20Z","timestamp":1779928880161,"version":"3.53.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>A 47-year-old woman presents to our clinic with a chief complaint of rhinorrhea; she had chronic hypertension managed with four antihypertensive drugs, including an ACE inhibitor. While dry cough is a well-known side effect associated with ACE inhibitors, this case highlights a common chief complaint yet less recognized side effect of ACE inhibitors and further emphasizes the idea that overall, angiotensin receptor blockers may be a better drug of choice in hypertension due to their favorable side effect profile.<\/jats:p>","DOI":"10.3389\/falgy.2024.1480569","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T06:14:10Z","timestamp":1731910450000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Angiotensin converting enzyme inhibitors vs. angiotensin receptor blockers in the management of chronic hypertension: a case of lisinopril-induced rhinorrhea"],"prefix":"10.3389","volume":"5","author":[{"given":"Alice A.","family":"Amudzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giro Richard","family":"Samale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Vela-Parada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000477660","article-title":"Case report of spontaneous remission of biopsy-proven idiopathic immune complex-mediated membranoproliferative glomerulonephritis","volume":"7","author":"Shah","year":"2017","journal-title":"Case Rep Nephrol Dial"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.29309\/tpmj\/2016.23.09.1712","article-title":"Ace inhibitors","volume":"23","author":"Nazir","year":"2016","journal-title":"Prof Med J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1177\/10600280211032404","article-title":"Underreported risk of lisinopril-induced angioedema in a veteran population","volume":"56","author":"Whitehead","year":"2022","journal-title":"Ann Pharmacother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e937895","DOI":"10.12659\/ajcr.937895","article-title":"Lisinopril-induced small bowel angioedema: an unusual cause of severe abdominal pain","volume":"23","author":"Johnson","year":"2022","journal-title":"Am J Case Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.22158\/rhs.v6n3p16","article-title":"Lisinopril induced visceral angioedema","volume":"6","author":"Jani","year":"2021","journal-title":"Res Health Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.annemergmed.2018.08.045","article-title":"40EMF outpatient lisinopril and losartan blood levels are associated with in-hospital acute kidney injury among patients with acute heart failure","volume":"72","author":"McNaughton","year":"2018","journal-title":"Ann Emerg Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/pds.1923","article-title":"Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril","volume":"19","author":"Johnson","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e14333","DOI":"10.7759\/cureus.14333","article-title":"Oroesophageal pemphigus vulgaris secondary to lisinopril use: a new side effect","volume":"13","author":"Tariq","year":"2021","journal-title":"Cureus"},{"key":"B9","doi-asserted-by":"publisher","first-page":"S1004","DOI":"10.14309\/01.ajg.0000709768.07287.a5","article-title":"S1930 lisinopril-induced oroesophageal pemphigus vulgaris: a previously unreported side effect","volume":"115","author":"Tariq","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1455613221141214","DOI":"10.1177\/01455613221141214","article-title":"Drug-induced rhinitis: narrative review","author":"Alromaih","year":"2022","journal-title":"Ear Nose Throat J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"bcr2014205462","DOI":"10.1136\/bcr-2014-205462","article-title":"ACE Inhibitors: upper respiratory symptoms","volume":"2014","author":"Pinargote","year":"2014","journal-title":"BMJ Case Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1111\/all.15223","article-title":"The prevalence of non-allergic rhinitis phenotypes in the general population: a cross-sectional study","volume":"77","author":"Avdeeva","year":"2022","journal-title":"Allergy"},{"key":"B13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jaci.2020.07.007","article-title":"Rhinitis 2020: a practice parameter update","volume":"146","author":"Dykewicz","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/pai.13164","article-title":"Update on rhinitis and rhinosinusitis","volume":"31","author":"Zicari","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/nejmra020526","article-title":"Pharmacogenomics \u2014 drug disposition, drug targets, and side effects","volume":"348","author":"Evans","year":"2003","journal-title":"N Engl J Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41371-023-00833-x","article-title":"Prevalence of hypertension in a rural community in southeastern Nigeria; an opportunity for early intervention","volume":"37","author":"Ezeala-Adikaibe","year":"2023","journal-title":"J Hum Hypertens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/HJH.0000000000003584","article-title":"Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021","volume":"42","author":"Basta","year":"2024","journal-title":"J Hypertens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/HJH.0000000000003424","article-title":"The prevalence and treatment of hypertension in veterans health administration, assessing the impact of the updated clinical guidelines","volume":"41","author":"Yamada","year":"2023","journal-title":"J Hypertens"},{"key":"B19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/ajh\/hpac053","article-title":"Prevalence, treatment, and control of hypertension among US women of reproductive age by race\/hispanic origin","volume":"35","author":"Ford","year":"2022","journal-title":"Am J Hypertens"},{"key":"B20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41371-021-00626-0","article-title":"Concerns about the prevalence estimates of undiagnosed hypertension among women aged 15\u201349 years in India","volume":"37","author":"Dutta","year":"2023","journal-title":"J Hum Hypertens"},{"key":"B21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ihj.2020.08.007","article-title":"ACEI-induced cough: a review of current evidence and its practical implications for optimal CV risk reduction","volume":"72","author":"Pinto","year":"2020","journal-title":"Indian Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/s0025-6196(12)60418-2","article-title":"Use of captopril as early therapy for renal scleroderma: a prospective study","volume":"60","author":"Beckett","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical pharmacokinetics of losartan","volume":"44","author":"Sica","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2165\/00003088-200038060-00005","article-title":"Pharmacokinetics and blood pressure response of losartan in end-stage renal disease","volume":"38","author":"Sica","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0091270003253367","article-title":"Pharmacokinetics, safety, and antihypertensive efficacy of losartan in combination with hydrochlorothiazide in hypertensive patients with renal impairment","volume":"43","author":"Dickson","year":"2003","journal-title":"J Clin Pharmacol"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1480569\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T06:14:13Z","timestamp":1731910453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2024.1480569\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":25,"alternative-id":["10.3389\/falgy.2024.1480569"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2024.1480569","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"article-number":"1480569"}}